Literature DB >> 23115464

Ticagrelor (brilinta), an antiplatelet drug for acute coronary syndrome.

Raeanne Fuller, Benjamin Chavez.   

Abstract

Ticagrelor (Brilinta) for acute coronary syndrome.

Entities:  

Year:  2012        PMID： 23115464      PMCID： PMC3474441     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  9 in total

1.  Benefits of ticagrelor debated as antiplatelet class approaches generic market.

Authors:  Thomas Morrow
Journal:  Manag Care       Date:  2011-10

2.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

3.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

Authors:  Sidney C Smith; Emelia J Benjamin; Robert O Bonow; Lynne T Braun; Mark A Creager; Barry A Franklin; Raymond J Gibbons; Scott M Grundy; Loren F Hiratzka; Daniel W Jones; Donald M Lloyd-Jones; Margo Minissian; Lori Mosca; Eric D Peterson; Ralph L Sacco; John Spertus; James H Stein; Kathryn A Taubert
Journal:  Circulation       Date:  2011-11-03       Impact factor: 29.690

4.  Role of ticagrelor in clopidogrel nonresponders: resistance is futile?

Authors:  Luke Tapp; Eduard Shantsila; Gregory Y H Lip
Journal:  Circulation       Date:  2010-03-01       Impact factor: 29.690

5.  Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study.

Authors:  Robert F Storey; Kevin P Bliden; Shankar B Patil; Arun Karunakaran; Rosemary Ecob; Kathleen Butler; Renli Teng; Cheryl Wei; Udaya S Tantry; Paul A Gurbel
Journal:  J Am Coll Cardiol       Date:  2010-07-13       Impact factor: 24.094

6.  Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial.

Authors:  Richard C Becker; Jean Pierre Bassand; Andrzej Budaj; Daniel M Wojdyla; Stefan K James; Jan H Cornel; John French; Claes Held; Jay Horrow; Steen Husted; Jose Lopez-Sendon; Riitta Lassila; Kenneth W Mahaffey; Robert F Storey; Robert A Harrington; Lars Wallentin
Journal:  Eur Heart J       Date:  2011-11-16       Impact factor: 29.983

Review 7.  Efficacy and safety of ticagrelor: a reversible P2Y12 receptor antagonist.

Authors:  Shawn D Anderson; Niren K Shah; Juwon Yim; Benjamin J Epstein
Journal:  Ann Pharmacother       Date:  2010-02-02       Impact factor: 3.154

8.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

9.  Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.

Authors:  Stefan James; Axel Akerblom; Christopher P Cannon; Håkan Emanuelsson; Steen Husted; Hugo Katus; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert Harrington; Richard Becker; Lars Wallentin
Journal:  Am Heart J       Date:  2009-04       Impact factor: 4.749
  9 in total
  2 in total

1.  Impact of Clopidogrel on Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: a National Retrospective Cohort Study.

Authors:  Aisling R Caffrey; Haley J Appaneal; Kerry L LaPlante; Vrishali V Lopes; Erlinda R Ulloa; Victor Nizet; George Sakoulas
Journal:  Antimicrob Agents Chemother       Date:  2022-04-13       Impact factor: 5.938

Review 2.  A Review of Antiplatelet Activity of Traditional Medicinal Herbs on Integrative Medicine Studies.

Authors:  Kyungho Kim; Kwang-Il Park
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-03       Impact factor: 2.629
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.